Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 343, pseudogene (RN7SL343P) is a human pseudogene related to the 7SL RNA, which is an essential non-coding RNA component of the signal recognition particle (SRP) complex involved in co-translational targeting of proteins to the endoplasmic reticulum[1][6]. While the functional 7SL RNA is crucial for SRP function, RN7SL343P is a processed pseudogene and does not encode a functional RNA or protein. The genome contains hundreds of 7SL RNA-related pseudogenes, generated by reverse transcription events[4][5]. Most of these pseudogenes, including RN7SL343P, are considered nonfunctional genomic elements, though a subset of pseudogenes have been shown in principle to exert regulatory effects such as serving as competitive endogenous RNAs, possibly modulating the expression of parental genes[2]. However, there is no direct evidence that RN7SL343P has such a regulatory function or involvement in human disease. It is not a therapeutic target or a drug-interacting molecule. Summary of specific aspects: - It is not a receptor, enzyme, transporter, or any canonical therapeutic target class[1]. - It is correctly named and not misspelled, though like most pseudogenes, it is mainly of genomic and evolutionary interest rather than of clinical, pharmacological, or biomarker relevance[1][4][5]. - There are no known drugs, mechanisms of action, biomarkers, or safety concerns related to RN7SL343P. - The vast majority of 7SL RNA-related pseudogenes, such as RN7SL343P, are not transcribed or functional, though rare exceptions may exist among pseudogenes in general[2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 343, pseudogene (RN7SL343P).